The primary objective of this study is to describe and assess participants' satisfaction with current vulvovaginal atrophy (VVA) treatment.
This study is designed as a multicenter, cross-sectional, descriptive, observational study.
Study Type
OBSERVATIONAL
Enrollment
831
Clínica Teknon
Barcelona, Spain
Hospital Universitario de Guadalajara
Guadalajara, Spain
Instituto Palacios
Madrid, Spain
Perception of Patient Satisfaction with Their Current Vulvovaginal Atrophy (VVA) Treatment by means of a questionnaire
The results will be determined by an evaluation the patient's selection of answers to 32 questions designed to determine the patient's use of, compliance with, and satisfaction with treatments for vulvovaginal atrophy. The questions have answers on a 5-point scale with the lowest score for dissatisfaction and the highest score for satisfaction
Time frame: Day 0
Perception of Patient Satisfaction with Long-term VVA Treatment of Vulvovaginal Atrophy by Means of a Questionnaire
The results will be determined by an evaluation the patient's selection of answers to 32 questions designed to determine the patient's use of, compliance with, and satisfaction with treatments for vulvovaginal atrophy. The questions have answers on a 5-point scale with the lowest score for dissatisfaction and the highest score for satisfaction
Time frame: Day 0
Factors that the Patient Identifies as Advantages of VVA Treatment by Means of a Questionnaire
The results will be determined by an evaluation the patient's selection of answers to 32 questions designed to determine the patient's use of, compliance with, and satisfaction with treatments for vulvovaginal atrophy. The questions have answers on a 5-point scale with the lowest score for dissatisfaction and the highest score for satisfaction
Time frame: Day 0
Factors that the Patient Identifies as Disadvantages of VVA Treatment by Means of a Questionnaire
The results will be determined by an evaluation the patient's selection of answers to 32 questions designed to determine the patient's use of, compliance with, and satisfaction with treatments for vulvovaginal atrophy. The questions have answers on a 5-point scale with the lowest score for dissatisfaction and the highest score for satisfaction
Time frame: Day 0
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Preferred Route of Administration and Treatment Schedule for VVA Determined by a Questionnaire
The results will be determined by an evaluation the patient's selection of answers to 32 questions designed to determine the patient's use of, compliance with, and satisfaction with treatments for vulvovaginal atrophy. The questions have answers on a 5-point scale with the lowest score for dissatisfaction and the highest score for satisfaction
Time frame: Day 0
Other Factors that Affect Adherence to VVA Treatment in the Patient´s Opinion as Determined by a Questionnaire
The results will be determined by an evaluation the patient's selection of answers to 32 questions designed to determine the patient's use of, compliance with, and satisfaction with treatments for vulvovaginal atrophy. The questions have answers on a 5-point scale with the lowest score for dissatisfaction and the highest score for satisfaction
Time frame: Day 0
Treatment Most Rejected by Patients According to the Opinion of the Healthcare Professional (HCP)
Time frame: Day 0
Preferred Route of Administration and Treatment Schedule in the Opinion of the HCP
Time frame: Day 0
Factors the HCP Identifies as Advantages of VVA Treatment by Means of a Questionnaire
The results will be determined by an evaluation the HCP's selection of answers to 32 questions designed to determine the patient's use of, compliance with, and satisfaction with treatments for vulvovaginal atrophy. The questions have answers on a 5-point scale with the lowest score for dissatisfaction and the highest score for satisfaction
Time frame: Day 0
Factors the HCP Identifies as Disadvantages of VVA Treatment by Means of a Questionnaire
The results will be determined by an evaluation the HCP's selection of answers to 32 questions designed to determine the patient's use of, compliance with, and satisfaction with treatments for vulvovaginal atrophy. The questions have answers on a 5-point scale with the lowest score for dissatisfaction and the highest score for satisfaction
Time frame: Day 0
HCP's Perception of Treatment Duration for Each Type of VVA Treatment
Time frame: Day 0
Other Factors that Influence Adherence According to the HCP Determined by Means of a Questionnaire
The results will be determined by an evaluation the HCP's selection of answers to questions designed to determine the patient's use of, compliance with, and satisfaction with treatments for vulvovaginal atrophy. The questions have answers on a 5-point scale with the lowest score for dissatisfaction and the highest score for satisfaction
Time frame: Day 0
HCP´s Perception about Patient Non-compliance to Each of the VVA Treatments
Time frame: Day 0
Treatment Duration for Each Type of VVA Treatment According to the HCP and the Patient
Time frame: Day 0
Patients' Preferred Treatment, Route of Administration and Treatment Schedule According to the HCP
Time frame: Day 0
Factors that According to the HCP and the Patient Influence the Patient's Decision to Discontinue Treatment
Time frame: Day 0
Factors Positively Affecting the Patient's Adherence to Each Treatment According to the HCP and Patient
Time frame: Day 0
VVA Acknowledgement by the Patient
Time frame: Day 0
VVA Symptoms Acknowledged by the Patient
Time frame: Day 0
Satisfaction with Current VVA Treatment by means of a Questionnaire
The results will be determined by an evaluation the patient's selection of answers to 32 questions designed to determine the patient's use of, compliance with, and satisfaction with treatments for vulvovaginal atrophy. The questions have answers on a 5-point scale with the lowest score for dissatisfaction and the highest score for satisfaction
Time frame: Day 0
Acknowledgement of the Advantages and Disadvantages of Treatment for VVA
Time frame: Day 0
Patient's Level of Compliance to the Treatment Scheme Prescribed by the HCP by Means of a Questionnaire
The results will be determined by an evaluation the patient's selection of answers to 32 questions designed to determine the patient's use of, compliance with, and satisfaction with treatments for vulvovaginal atrophy. The questions have answers on a 5-point scale with the lowest score for dissatisfaction and the highest score for satisfaction
Time frame: Day 0
Importance Given by the Patient to Comply with the Treatment for VVA
Time frame: Day 0
Patient Compliance with HCP instructions Regarding the Treatment Dosage by Means of a Questionnaire
The results will be determined by an evaluation the patient's selection of answers to 32 questions designed to determine the patient's use of, compliance with, and satisfaction with treatments for vulvovaginal atrophy. The questions have answers on a 5-point scale with the lowest score for dissatisfaction and the highest score for satisfaction
Time frame: Day 0
Reasons for not Following HCP Instructions for Treatment of VVA
Time frame: Day 0
Importance Patient Gives to Follow the Instructions of her Doctor About the Treatment for VVA
Time frame: Day 0
Cervantes Quality of Life (QOL) Questionnaire Total Score and Domain Scores
Time frame: Day 0
Symptoms that Most Benefit from VVA Treatment According to the Patient
Time frame: Day 0
Time to Improvement in VVA Symptoms According to the Patient
Time frame: Day 0
Effect of Educational Level, Marital Status, Age, and Geographic Location on Treatment Adherence for VVA
Time frame: Day 0